CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 625 of 764 entries

View as:

Causes and Factors Associated With Outcomes in Community-acquired Sepsis and Severe Sepsis in Northeast Thailand

Phase: N/A Priority: Normal

NCT ID: NCT02217592 Org: User:

Start: 05/20/12 End: 02/28/17 Due: 02/28/18

(GluEsk) Glutamate and Esketamine

Phase: N/A Priority: Normal

NCT ID: NCT06432322 Org: User:

Start: 06/14/24 End: 03/26/25 Due: 03/26/26

Ivermectin Safety in Small Children

Phase: N/A Priority: Normal

NCT ID: NCT04332068 Org: User:

Start: 11/18/23 End: 12/31/24 Due: 12/31/25

Tenofovir in Pregnancy to Prevent Mother to Child Transmission of Hepatitis B.

Phase: N/A Priority: Normal

NCT ID: NCT04114890 Org: User:

Start: 01/08/21 End: 09/29/23 Due: 09/29/24

A New Way of Looking at Your Lungs

Phase: N/A Priority: Normal

NCT ID: NCT01949402 Org: User:

Start: 02/28/14 End: 07/31/16 Due: 07/31/17

Dapagliflozin During Exercise for the PrevenTion of Hypoglycaemia

Phase: N/A Priority: Normal

NCT ID: NCT03537131 Org: User:

Start: 06/02/18 End: 07/14/21 Due: 07/14/22

A Phase 1/2b Study of an Investigational Malaria Vaccination Strategy in 5-17 Month Old Infants and Children in Burkina Faso

Phase: N/A Priority: Normal

NCT ID: NCT01635647 Org: User:

Start: 11/30/12 End: 09/30/14 Due: 09/30/15

Sepsis-3 Study in Northeast Thailand

Phase: N/A Priority: Normal

NCT ID: NCT03379402 Org: User:

Start: 02/01/18 End: 12/31/24 Due: 12/31/25

Dose Adaptation of Capecitabine Using Mobile Phone Toxicity Monitoring

Phase: N/A Priority: Normal

NCT ID: NCT01053104 Org: User:

Start: 11/30/09 End: 04/30/11 Due: 04/30/12

Protection Against Pneumococcal Infection in Children With T1DM

Phase: N/A Priority: Normal

NCT ID: NCT01939522 Org: User:

Start: 08/31/13 End: 01/31/17 Due: 01/31/18

Investigating Enteric Fever - Salmonella Typhi and Paratyphi Challenge Study

Phase: N/A Priority: Normal

NCT ID: NCT02192008 Org: User:

Start: 12/31/14 End: 05/26/22 Due: 05/26/23

Quality of Life Measures in Patients With Retinal Degeneration

Phase: N/A Priority: Normal

NCT ID: NCT02814435 Org: User:

Start: 07/31/16 End: 10/31/17 Due: 10/31/18

MEK and MET Inhibition in Colorectal Cancer

Phase: N/A Priority: Normal

NCT ID: NCT02510001 Org: User:

Start: 11/30/14 End: 12/03/18 Due: 12/03/19

Can we Use Estrogen-containing Therapy to Improve Pain in Women After Menopause With Hand Osteoarthritis?

Phase: N/A Priority: Normal

NCT ID: NCT04036929 Org: User:

Start: 05/09/19 End: 12/10/21 Due: 12/10/22

Investigating Meningococcal Vaccines in Adults

Phase: N/A Priority: Normal

NCT ID: NCT02398396 Org: User:

Start: 04/30/15 End: 06/13/19 Due: 06/13/20

Studying Movement Control in Parkinson's Disease Using Closed Loop Deep Brain Stimulation

Phase: N/A Priority: Normal

NCT ID: NCT02585154 Org: User:

Start: 01/08/16 End: 12/31/19 Due: 12/31/20

QuEST - Quick and Easy Scrub Typhus Diagnostic Tools

Phase: N/A Priority: Normal

NCT ID: NCT06675110 Org: User:

Start: 07/17/24 End: 04/30/25 Due: 04/30/26

Providing Breastfeeding Support After Discharge From Hospital to Improve Growth and Development of Malnourished Infants

Phase: N/A Priority: Normal

NCT ID: NCT06372418 Org: User:

Start: 05/31/24 End: 02/28/27 Due: 02/28/28

Complement 2: Blood Donations to Develop Vaccines Against Infectious Diseases

Phase: N/A Priority: Normal

NCT ID: NCT01945307 Org: User:

Start: 10/31/13 End: 03/31/23 Due: 03/31/24

Immediate Versus Deferred Antiretroviral Therapy for HIV-Associated Tuberculous Meningitis

Phase: N/A Priority: Normal

NCT ID: NCT00433719 Org: User:

Start: 09/30/05 End: 12/31/08 Due: 12/31/09

Trial of Remote Evaluation and Treatment of Gestational Diabetes Mellitus

Phase: N/A Priority: Normal

NCT ID: NCT01916694 Org: User:

Start: 09/30/13 End: 02/29/16 Due: 02/28/17

Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy

Phase: N/A Priority: Normal

NCT ID: NCT01120028 Org: User:

Start: 09/30/10 End: 03/31/20 Due: 03/31/21

Safety of Tuberculosis Vaccine, MVA85A, Administered by the Aerosol Route and the Intradermal Route

Phase: N/A Priority: Normal

NCT ID: NCT01497769 Org: User:

Start: 09/30/11 End: 04/30/13 Due: 04/30/14

The Oxford Pleural Infection Endotyping Study

Phase: N/A Priority: Normal

NCT ID: NCT06513689 Org: User:

Start: 06/20/21 End: 06/20/24 Due: 06/20/25

A Challenge Study to Assess the Safety, Immunogenicity and Efficacy of a Malaria Vaccine Candidate

Phase: N/A Priority: Normal

NCT ID: NCT02927145 Org: User:

Start: 10/17/16 End: 06/27/19 Due: 06/27/20

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Causes and Factors Associated With Outcomes in Community-acquired Sepsis and Severe Sepsis in Northeast Thailand	NCT02217592	University of Oxford	user2@example.com	None	2012-05-20	2017-02-28	2018-02-28	-	-	2025-07-14
(GluEsk) Glutamate and Esketamine	NCT06432322	University of Oxford	user2@example.com	None	2024-06-14	2025-03-26	2026-03-26	-	-	2025-07-14
Ivermectin Safety in Small Children	NCT04332068	University of Oxford	user2@example.com	None	2023-11-18	2024-12-31	2025-12-31	-	-	2025-07-14
Tenofovir in Pregnancy to Prevent Mother to Child Transmission of Hepatitis B.	NCT04114890	University of Oxford	user2@example.com	None	2021-01-08	2023-09-29	2024-09-29	-	-	2025-07-14
A New Way of Looking at Your Lungs	NCT01949402	University of Oxford	user2@example.com	None	2014-02-28	2016-07-31	2017-07-31	-	-	2025-07-14
Dapagliflozin During Exercise for the PrevenTion of Hypoglycaemia	NCT03537131	University of Oxford	user2@example.com	None	2018-06-02	2021-07-14	2022-07-14	-	-	2025-07-14
A Phase 1/2b Study of an Investigational Malaria Vaccination Strategy in 5-17 Month Old Infants and Children in Burkina Faso	NCT01635647	University of Oxford	user2@example.com	None	2012-11-30	2014-09-30	2015-09-30	-	-	2025-07-14
Sepsis-3 Study in Northeast Thailand	NCT03379402	University of Oxford	user2@example.com	None	2018-02-01	2024-12-31	2025-12-31	-	-	2025-07-14
Dose Adaptation of Capecitabine Using Mobile Phone Toxicity Monitoring	NCT01053104	University of Oxford	user2@example.com	None	2009-11-30	2011-04-30	2012-04-30	-	-	2025-07-14
Protection Against Pneumococcal Infection in Children With T1DM	NCT01939522	University of Oxford	user2@example.com	None	2013-08-31	2017-01-31	2018-01-31	-	-	2025-07-14
Investigating Enteric Fever - Salmonella Typhi and Paratyphi Challenge Study	NCT02192008	University of Oxford	user2@example.com	None	2014-12-31	2022-05-26	2023-05-26	-	-	2025-07-14
Quality of Life Measures in Patients With Retinal Degeneration	NCT02814435	University of Oxford	user2@example.com	None	2016-07-31	2017-10-31	2018-10-31	-	-	2025-07-14
MEK and MET Inhibition in Colorectal Cancer	NCT02510001	University of Oxford	user2@example.com	None	2014-11-30	2018-12-03	2019-12-03	-	-	2025-07-14
Can we Use Estrogen-containing Therapy to Improve Pain in Women After Menopause With Hand Osteoarthritis?	NCT04036929	University of Oxford	user2@example.com	None	2019-05-09	2021-12-10	2022-12-10	-	-	2025-07-14
Investigating Meningococcal Vaccines in Adults	NCT02398396	University of Oxford	user2@example.com	None	2015-04-30	2019-06-13	2020-06-13	-	-	2025-07-14
Studying Movement Control in Parkinson's Disease Using Closed Loop Deep Brain Stimulation	NCT02585154	University of Oxford	user2@example.com	None	2016-01-08	2019-12-31	2020-12-31	-	-	2025-07-14
QuEST - Quick and Easy Scrub Typhus Diagnostic Tools	NCT06675110	University of Oxford	user2@example.com	None	2024-07-17	2025-04-30	2026-04-30	-	-	2025-07-14
Providing Breastfeeding Support After Discharge From Hospital to Improve Growth and Development of Malnourished Infants	NCT06372418	University of Oxford	user2@example.com	None	2024-05-31	2027-02-28	2028-02-28	-	-	2025-07-14
Complement 2: Blood Donations to Develop Vaccines Against Infectious Diseases	NCT01945307	University of Oxford	user2@example.com	None	2013-10-31	2023-03-31	2024-03-31	-	-	2025-07-14
Immediate Versus Deferred Antiretroviral Therapy for HIV-Associated Tuberculous Meningitis	NCT00433719	University of Oxford	user2@example.com	None	2005-09-30	2008-12-31	2009-12-31	-	-	2025-07-14
Trial of Remote Evaluation and Treatment of Gestational Diabetes Mellitus	NCT01916694	University of Oxford	user2@example.com	None	2013-09-30	2016-02-29	2017-02-28	-	-	2025-07-14
Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy	NCT01120028	University of Oxford	user2@example.com	None	2010-09-30	2020-03-31	2021-03-31	-	-	2025-07-14
Safety of Tuberculosis Vaccine, MVA85A, Administered by the Aerosol Route and the Intradermal Route	NCT01497769	University of Oxford	user2@example.com	None	2011-09-30	2013-04-30	2014-04-30	-	-	2025-07-14
The Oxford Pleural Infection Endotyping Study	NCT06513689	University of Oxford	user2@example.com	None	2021-06-20	2024-06-20	2025-06-20	-	-	2025-07-14
A Challenge Study to Assess the Safety, Immunogenicity and Efficacy of a Malaria Vaccine Candidate	NCT02927145	University of Oxford	user2@example.com	None	2016-10-17	2019-06-27	2020-06-27	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance